Experimental Drug Appears to Slow Down Alzheimer’s Disease

November 30, 2022 by TWN Staff
Experimental Drug Appears to Slow Down Alzheimer’s Disease
Cells in an Alzheimer's-affected brain. (NATIONAL INSTITUTE ON AGING, NIH/AP)

An experimental drug that removes a substance called amyloid — a toxic protein — from the brain appears to slow down Alzheimer’s disease.

The drug, lecanemab, reduced the rate of cognitive decline by 27% in a study of nearly 1,800 people in the early stages of Alzheimer’s, scientists reported at the Clinical Trials on Alzheimer’s Disease meeting in San Francisco, California, on Tuesday.

The study was also published in this week’s edition of The New England Journal of Medicine.

According to Dr. Christopher van Dyck, who directs the Yale Alzheimer’s Disease Research Center and presented an overview of the study at the meeting, patients who got infusions of lecanemab scored about half a point better on a zero-to-18-point scale of mental functioning, a slight but statistically significant difference.

Lecanemab is expected to win preliminary approval from the Food and Drug Administration in January 2023, based on its ability to reduce amyloid. 

But questions about the drug remain. The drug appears to have caused serious side effects like brain swelling and bleeding in more than one in five people who took the medicine, compared to 10% of those who received a placebo. 

Nevertheless, the Alzheimer’s Association called for approval of the medicine, saying it will allow patients more time to live independently and participate in daily life. 

“It could mean many months more of recognizing their spouse, children and grandchildren,” the group said in a statement. “Treatments that deliver tangible benefits to those living with mild cognitive impairment due to Alzheimer’s and early Alzheimer’s dementia are as valuable as treatments that extend the lives of those with other terminal diseases.”

A+
a-
  • Alzheimer's disease
  • experimental drug
  • lecanemab
  • In The News

    Health

    Voting

    Research

    How Ancient Reptile Footprints Are Rewriting the History of When Animals Evolved to Live on Land

    WASHINGTON (AP) — Scientists in Australia have identified the oldest known fossil footprints of a reptile-like animal, dated to around 350 million years... Read More

    WASHINGTON (AP) — Scientists in Australia have identified the oldest known fossil footprints of a reptile-like animal, dated to around 350 million years ago. The discovery suggests that after the first animals emerged from the ocean around 400 million years ago, they evolved the ability to live exclusively on land much... Read More

    May 9, 2025
    by Beth McCue
    Energy Dept. Designates Cal Poly Pier as Wave Energy Test Site

    AVILA BEACH, Calif. — Extending 3,000 feet over the deep blue waters of San Luis Obispo Bay in California stands... Read More

    AVILA BEACH, Calif. — Extending 3,000 feet over the deep blue waters of San Luis Obispo Bay in California stands the Cal Poly Pier. The facility has recently been designated an open water test site for industry evaluations of marine energy devices and systems by the... Read More

    April 30, 2025
    by Tom Ramstack
    Trump Administration Dismisses Scientists Preparing Climate Change Report

    WASHINGTON — The Trump administration this week dismissed all contributors to a study designed to help the U.S. government prepare... Read More

    WASHINGTON — The Trump administration this week dismissed all contributors to a study designed to help the U.S. government prepare for climate change. The study, called the National Climate Assessment, was mandated by Congress under the Global Change Research Act of 1990. It was due for... Read More

    March 24, 2025
    by Dan McCue
    Promise of Offshore Wind Technology Undiminished by US Political Climate

    NATIONAL HARBOR, Md. — Despite the political headwinds currently buffeting the offshore wind sector as a whole in the United... Read More

    NATIONAL HARBOR, Md. — Despite the political headwinds currently buffeting the offshore wind sector as a whole in the United States, work continues on how to foster the industry’s success over the long term. One example of that was the floating wind turbine platform developed at... Read More

    Researchers Find a Hint at How to Delay Alzheimer's Symptoms. Now They Have to Prove It

    An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s,... Read More

    An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught up in Trump administration funding delays. The early results — a scientific first — were published Wednesday even as... Read More

    Jobs Lost in Every State and Lifesaving Cures not Discovered: Possible Impacts of Research Cuts

    WASHINGTON (AP) — Rural cancer patients may miss out on cutting-edge treatments in Utah. Therapies for intellectual disorders could stall... Read More

    WASHINGTON (AP) — Rural cancer patients may miss out on cutting-edge treatments in Utah. Therapies for intellectual disorders could stall in Maryland. Red states and blue states alike are poised to lose jobs in research labs and the local businesses serving them. Ripple effects of the... Read More

    News From The Well
    scroll top